John Dormandy - Publications, H-index & Citations

John Dormandy

University College London

51H指数

274论文数

2.7W被引数

收录论文 22

发表时间

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

VASCULAR MEDICINE

IF3.3

2015-08-12

OAAI

Jaff, Michael R.; White, Christopher J.; Hiatt, William R.; Fowkes, Gerry R.; Dormandy, John; Razavi, Mahmood; Reekers, Jim; Norgren, Lars

Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: An analysis of the PROactive study population

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2012-12-01

186

PREAI

Doehner, Wolfram; Erdmann, Erland; Cairns, Richard; Clark, Andrew L.; Dormandy, John A.; Ferrannini, Ele; Anker, Stefan D.

Pioglitazone and bladder cancer Reply

LANCET

IF88.5

2011-10-01

OAAI

Erdmann, Erland; Dormandy, John A.; Massi-Benedetti, Massimo; Spanheimer, Robert

The Fate of the Claudicant-A Prospective Study of 1969 Claudicants (Reprinted from Eur J Vasc Endovasc Surg, vol 5, pg 131-33, 1991)

European Journal of Vascular and Endovascular Surgery

IF6.8

2011-09-01

OAAI

Dormandy, J. A.; Murray, G. D.

High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive

DIABETES OBESITY & METABOLISM

IF5.7

2011-06-21

PREAI

Ferrannini, E.; Betteridge, D. J.; Dormandy, J. A.; Charbonnel, B.; Wilcox, R. G.; Spanheimer, R.; Erdmann, E.; DeFronzo, R. A.; Laakso, M.

Regarding Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial Reply

JOURNAL OF VASCULAR SURGERY

IF3.6

2011-05-01

OAAI

Belch, Jill J. F.; Dormandy, John

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial

JOURNAL OF VASCULAR SURGERY

IF3.6

2010-10-01

258

OAAI

Belch, Jill J. F.; Dormandy, John

The Next 10 years in the Management of Peripheral Artery Disease: Perspectives from The 'PAD 2009' Conference 外周动脉疾病管理的未来10年: “pad 2009” 会议的观点

European Journal of Vascular and Endovascular Surgery

IF6.8

2010-09-01

OAAI

Norgren, L.; Hiatt, W. R.; Dormandy, J. A.; Hirsch, A. T.; Jaff, M. R.; Diehm, C.; Baumgartner, I.; Belch, J. J. F.

Impact of peripheral arterial disease in patients with diabetes-Results from PROactive (PROactive 11)

ATHEROSCLEROSIS

IF5.7

2009-01-01

PREAI

Dormandy, J. A.; Betteridge, D. J.; Schernthaner, G.; Pirags, V.; Norgren, L.

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes An Overview of Data from PROactive

DRUG SAFETY

IF3.8

2009-01-01

202

PREAI

Dormandy, John; Bhattacharya, Mondira; de Bruyn, Anne-Ruth van Troostenburg

Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08)

DIABETES CARE

IF16.6

2007-11-01

242

OAAI

Erdmann, Erland; Charbonnel, Bernard; Wilcox, Robert G.; Skene, Allan M.; Massi-Benedetti, Massimo; Yates, John; Tan, Meng; Spanheimer, Robert; Standl, Eberhard; Dormandy, John A.

PROactive 06:: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK

DIABETIC MEDICINE

IF3.4

2007-06-25

PREAI

Valentine, W. J.; Bottomley, J. M.; Palmer, A. J.; Braendle, M.; Foos, V.; Williams, R.; Dormandy, J. A.; Yates, J.; Tan, M. H.; Massi-Benedetti, M.

Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes

JOURNAL OF VASCULAR SURGERY

IF3.6

2007-05-01

OAAI

Nehler, Mark R.; Brass, Eric P.; Anthony, Richard; Dormandy, John; Jiao, Jenny; McNamara, Thomas O.; Hiatt, William R.

Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke - Results from PROactive (PROspective pioglitAzone Clinical Trial in macroVascular Events 04)

STROKE

IF8.9

2007-03-01

401

OAAI

Wilcox, Robert; Bousser, Marie-Germaine; Betteridge, D. John; Schernthaner, Guntram; Pirags, Valdis; Kupfer, Stuart; Dormandy, John

Inter-society consensus for the management of peripheral arterial disease (TASC II)

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

IF6.8

2007-01-01

3.7K

OAAI

Norgren, L.; Hiatt, W. R.; Dormandy, J. A.; Nehler, M. R.; Harris, K. A.; Fowkes, F. G. R.

Inter-society consensus for the management of peripheral arterial disease (TASC II)

JOURNAL OF VASCULAR SURGERY

IF3.6

2007-01-01

3.4K

OAAI

Norgren, L.; Hiatt, W. R.; Dormandy, J. A.; Nehler, M. R.; Harris, K. A.; Fowkes, F. G. R.; Liapis, Christos D.

The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease

BRITISH JOURNAL OF SURGERY

IF8.7

2006-04-11

OAAI

Vig, S.; Chitolie, A.; Bevan, D.; Dormandy, J.; Thompson, M. M.; Halliday, A.

Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia

JOURNAL OF VASCULAR SURGERY

IF3.6

2006-04-01

108

OAAI

Brass, EP; Anthony, R; Dormandy, J; Hiatt, WR; Jiao, J; Nakanishi, A; McNamara, T; Nehler, M

Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial 严重肢体缺血的治疗性血管生成: 肝细胞生长因子治疗性血管生成临床试验的设计

VASCULAR MEDICINE

IF3.3

2004-08-01

OAAI

Powell, RJ; Dormandy, J; Simons, M; Morishita, R; Annex, BH

Prevalence and risk of thrombophilia defects in vascular patients 血管患者血栓形成缺陷的患病率和风险

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

IF6.8

2004-08-01

OAAI

Vig, S; Chitolie, A; Sleight, S; Bevan, D; Dormandy, J; Thompson, MM; Halliday, A

研究方向